Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Pharmacology, Tabriz University of Medical Sciences, Tabriz, Iran.
Mol Biol Rep. 2022 Jul;49(7):6701-6716. doi: 10.1007/s11033-022-07270-y. Epub 2022 Feb 27.
Ginsenosides belong to a group of steroid glycosides that are extracted from the plant genus Panax (ginseng). This plant has been used for a long time for the treatment of a variety of disorders in traditional medicine. Recent studies have assessed the biological impact of Ginsenosides in cell culture or animal models. Animal studies have shown their beneficial impacts in the remedy of pathological conditions in different tissues. The ameliorating effects of Ginsenosides in diverse pathogenic conditions can be attributed to their effects on the production of reactive oxygen species. These substances mainly affect the activity of AMPK/AKT and PI3K/AKT pathways. The beneficial effects of Ginsenosides have been appraised in diabetes-related complications, spinal cord injury, cerebral ischemia, myocardial ischemia, and other disorders which are associated with oxidative stress. Moreover, these substances have been shown to interfere with the pathologic conditions during carcinogenesis. In the current study, we explain these impacts in two distinct sections including non-neoplastic conditions and neoplastic conditions.
人参皂苷属于甾体糖苷类化合物,从人参属植物(人参)中提取。这种植物在传统医学中已被长期用于治疗各种疾病。最近的研究评估了人参皂苷在细胞培养或动物模型中的生物学影响。动物研究表明,它们在治疗不同组织的病理状况方面具有有益的影响。人参皂苷在多种致病条件下的改善作用可归因于其对活性氧物质产生的影响。这些物质主要影响 AMPK/AKT 和 PI3K/AKT 通路的活性。人参皂苷在糖尿病相关并发症、脊髓损伤、脑缺血、心肌缺血和其他与氧化应激相关的疾病中的有益作用已得到评估。此外,这些物质已被证明可干扰致癌过程中的病理状况。在本研究中,我们将在非肿瘤和肿瘤两种不同情况下解释这些影响。